DNA repair gene X-ray repair cross-complementing group 1 and Xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: A study from North India

DNA and Cell Biology

Volumn 29, Issue 4, 2010, Pages 183-190

  Mandal, Raju K ^a   Gangwar, Ruchika ^a   Mandhani, Anil ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN; DNA BINDING PROTEIN; ERCC2 PROTEIN, HUMAN; PROSTATE SPECIFIC ANTIGEN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

ADULT; ARTICLE; BONE METASTASIS; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; ETHNICITY; EXON; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; BLOOD; BONE TUMOR; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; SMOKING;

AGED; BONE NEOPLASMS; DNA-BINDING PROTEINS; EXONS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SMOKING; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 77951250828     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0956     Document Type: Article

References (28)

1. Andersson, S.O., Baron, J., Bergström, R., Lindgren, C., Wolk, A., and Adami, H.O. (1996). Lifestyle factors and prostate cancer risk: a case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 5, 509-513. (Pubitemid 26235016)
2. Bau, D.T., Wu, H.C., Chiu, C.F., Lin, C.C., Hsu, C.M., Wang, C.L., Wang, R.F., and Tsai, F.J. (2007). Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res 27, 2893-2896.
3. Benhamou, S., and Sarasin, A. (2005). ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 161, 1-14.
4. Chacko, P., Rajan, B., Joseph, T., Mathew, B.S., and Pillai, M.R. (2005). Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 89, 15-21.
5. Evans, E., Moggs, J.G., Hwang, J.R., Egly, J.M., and Wood, R.D. (1997). Mechanism of open complex and dual incision formation by human nucleotide excision repair factors. EMBO J 16, 6559-6573.
6. Gangwar, R., Manchanda, P.K., and Mittal, R.D. (2009). Implications of XRCC1, XPD and APE1 gene polymorphism in North Indian population: a comparative approach in different ethnic groups worldwide. Genetica 136, 163-169.
7. Geng, J., Zhang, Q., Zhu, C., Wang, J., and Chen, L. (2009). XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis. Urology 74, 648-653.
8. Gleason, D.F., and Mellinger, G.T. (1974). Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 111, 58-64.
9. Hickey, K., Do, K.A., and Green, A. (2001). Smoking and prostate cancer. Epidemiol Rev 23, 115-125.
10. Hsu, F.C., Sun, J., Wiklund, F., Isaacs, S.D., Wiley, K.E., Purcell, L.D., Gao, Z., Stattin, P., Zhu, Y., Kim, S.T., Zhang, Z., Liu, W., Chang, B.L.,Walsh, P.C., Duggan, D., Carpten, J.D.,Isaacs, W.B., Grönberg, H., Xu, J., and Zheng, S.L. (2009). A novel prostate cancer susceptibility locus at 19q13. Cancer Res 69, 2720-2723.
11. Hu, Z., Ma, H., Chen, F., Wei, Q., and Shen, H. (2005). XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14, 1810-1818. (Pubitemid 40995099)
12. Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R.C., Ghafoor, A., Feuer, E.J., and Thun, M.J. (2005). Cancer statistics. CA Cancer J Clin 55, 10-30.
13. Kowalski, M., Przybylowska, K., Rusin, P., Olszewski, J., Morawiec-Sztandera, A., Bielecka-Kowalska, A., Pietruszewska, W., Mlynarski, W., Szemaraj, J., and Majsterek, I. (2009). Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res 13, 28-37.
14. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., and Hemminki, K. (2000). Environmental and heritable factors in the causation of cancer - analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343, 78-85.
15. Majumder, M., Sikdar, N., Ghosh, S., and Roy, B. (2007). Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acet-ylators. Int J Cancer 120, 2148-2156.
16. Masson, M., Niedergang, C., Schreiber, V., Muller, S., Menissierde Murcia, J., and de Murcia, G. (1998). XRCC1 is specifically associated with poly (ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18, 3563-3571.
17. Miller, S.A., Dykes, D.D., and Polesky, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215.
18. Ritchey, J.D., Huang, W.Y., Chokkalingam, A.P., Gao, Y.T., Deng, J., Levine, P., Stanczyk, F.Z., and Hsing, A.W. (2005). Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol Biomarkers Prev 14, 1703-1709.
19. Rybicki, B.A., Conti, D.V., Moreira, A., Cicek, M., Casev, G., and Witte, J.S. (2004). DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1, 23-29.
20. Sancar, A., and Tang, M.S. (1993). Nucleotide excision repair. Photochem Photobiol 57, 905-921.
21. Sanyal, S., Festa, F., Sakano, S., Zhang, Z., Steineck, G., Norming, U., Wijkstrom, H., Larsson, P., Kumar, R., and Hemminki, K. (2004). Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25, 729-734.
22. Shields, P.G., and Harris, C.C. (1991). Molecular epidemiology and the genetics of environmental cancer. JAMA 266, 681-687.
23. Sinha, R., Anderson, D.E., McDonald, S.S., and Greenwald, P. (2003). Cancer risk and diet in India. J Postgrad Med 49, 222-228.
24. Sturgis, E.M., Castillo, E.J., Li, L., Zheng, R., Eicher, S.A., Clayman, G.L., Strom, S.S., Spitz, M.R., and Wei, Q. (1999). Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20, 2125-2129.
25. Tang, D., Cho, S., Rundle, A., Chen, S., Phillips, D., Zhou, J., Hsu, Y., Schnabel, F., Estabrook, A., and Perera, F.P. (2002). Polymorphisms in the DNA repair enzyme XPD are associated with increased levels of PAH-DNA adducts in a case-control study of breast cancer. Breast Cancer Res Treat 75, 159-166.
26. Wang, M., Gu, D., Zhang, Z., Zhou, J., and Zhang,Z. (2009a). XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis. J Toxicol Environ Health A 72, 698-705.
27. Wang, Y., Yang, H., Li, H., Li, L., Wang, H., Liu, C., and Zheng, Y. (2009b). Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: A meta analysis. Cancer Lett 285, 134-140.
28. Winsey, S.L., Haldar, N.A., Marsh, H.P., Bunce, M., Marshall, S.E., Harris, A.L., Wojnarowska, F., and Welsh, K.I. (2000). A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60, 5612-5616.